World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
136
Citations
56481
World Ranking
2001
National Ranking
207

John G. Gribben publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where John G. Gribben sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 820 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

John G. Gribben D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where John G. Gribben sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 136 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

John G. Gribben is affiliated with Queen Mary University of London in the United Kingdom. Their research primarily spans medicine with a focus on hematology, oncology, molecular biology, genetics, and pathology. The scholar has contributed extensively to lymphoma diagnosis and treatment, chronic lymphocytic leukemia research, acute myeloid leukemia research, and CAR-T cell therapy research. Additional research topics include hematopoietic stem cell transplantation, immune cell function and interaction, and viral-associated cancers and disorders.

Frequent publication venues for their work include:

  • Blood
  • HemaSphere
  • bioRxiv (Cold Spring Harbor Laboratory)
  • British Journal of Haematology
  • Haematologica

Among their recent papers are:

  • The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee (2022, Blood)
  • Bone marrow niches in haematological malignancies (2020, Nature reviews. Cancer)
  • Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA) (2021, Annals of Oncology)
  • Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations (2023, Blood)
  • Genomic profiling for clinical decision making in lymphoid neoplasms (2022, Blood)

Their frequent co-authors include:

  • Pedro R. Cutillas
  • Dominique Bonnet
  • Andrew Clear
  • Jude Fitzgibbon
  • Paola Ghione

John G. Gribben's main fields of study are Medicine and Biochemistry, Genetics and Molecular Biology, with key subfields including Molecular Biology, Hematology, Oncology, Pathology and Forensic Medicine, and Genetics.

They have been recognized as a Fellow of The Academy of Medical Sciences in the United Kingdom.

Best Publications

  • Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T cell proliferation

    Gordon J. Freeman;John G. Gribben;Vassiliki A. Boussiotis;Judy W. Ng

  • ZAP-70 Compared with Immunoglobulin Heavy-Chain Gene Mutation Status as a Predictor of Disease Progression in Chronic Lymphocytic Leukemia

    Laura Z. Rassenti;Lang Huynh;Tracy L. Toy;Liguang Chen

  • Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.

    Anupama Reddy;Jenny Zhang;Nicholas S. Davis;Andrea B. Moffitt

  • Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma.

    J G Gribben;A S Freedman;D Neuberg;D C Roy

  • Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation.

    Claude D. Gimmi;Gordon J. Freeman;John G. Gribben;Gary Gray

  • Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma

    Jessica Okosun;Csaba Bödör;Jun Wang;Shamzah Araf

  • Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug

    Alan G. Ramsay;Amy J. Johnson;Abigail M. Lee;Güllü Gorgün

  • Chronic lymphocytic leukaemia.

    Thomas J. Kipps;Freda K. Stevenson;Catherine J. Wu;Carlo M. Croce

  • B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2.

    Claude D. Gimmi;Gordon J. Freeman;John G. Gribben;Kanji Sugita

  • Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial

    Carol Moreno;Richard Greil;Fatih Demirkan;Alessandra Tedeschi

  • Transplantation of anergic histoincompatible bone marrow allografts.

    Eva C. Guinan;Vassiliki A. Boussiotis;Donna Neuberg;Lisa LaVita Brennan

  • T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production.

    John C. Riches;Jeffrey K. Davies;Fabienne McClanahan;Rewas Fatah

  • Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7.

    Gordon J. Freeman;Gary S. Gray;Claude D. Gimmi;David B. Lombard

  • Activated Pancreatic Stellate Cells Sequester CD8+ T Cells to Reduce Their Infiltration of the Juxtatumoral Compartment of Pancreatic Ductal Adenocarcinoma

    Abasi Ene–Obong;Andrew J. Clear;Jennifer Watt;Jennifer Watt;Jun Wang

  • Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production.

    G J Freeman;F Borriello;R J Hodes;H Reiser

  • Rituximab and CHOP Induction Therapy for Newly Diagnosed Mantle-Cell Lymphoma: Molecular Complete Responses Are Not Predictive of Progression-Free Survival

    Orion M. Howard;John G. Gribben;Donna S. Neuberg;Michael Grossbard

  • All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment.

    John G. Gribben;Arnold S. Freedman;Sunhee D. Woo;Kelly Blake

  • Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity

    Eva C. Guinan;John G. Gribben;Vicki A. Boussiotis;Gordon J. Freeman

  • Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma.

    JG Gribben;D Neuberg;AS Freedman;CD Gimmi

  • Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34- fraction

    David C. Taussig;Jacques Vargaftig;Farideh Miraki-Moud;Emmanuel Griessinger

Frequent Co-Authors

Lee M. Nadler
Lee M. Nadler Harvard University
Donna Neuberg
Donna Neuberg Harvard University
Arnold S. Freedman
Arnold S. Freedman Harvard University
Jude Fitzgibbon
Jude Fitzgibbon Queen Mary University of London
Thomas J. Kipps
Thomas J. Kipps University of California, San Diego
Gordon J. Freeman
Gordon J. Freeman Harvard University
Robert J. Soiffer
Robert J. Soiffer Harvard University
Jerome Ritz
Jerome Ritz Harvard University
Laura Z. Rassenti
Laura Z. Rassenti University of California, San Diego
Jennifer R. Brown
Jennifer R. Brown Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare careers outside traditional medical school, several online degree paths offer flexibility and affordability. Many students choose specialized programs, such as medical billing and coding, which can be completed quickly and at a lower cost. If you're curious about the commitment needed, check out the average cost of medical billing and coding program to get a sense of tuition and fees.

Ambitious nurses looking to advance their careers can also explore affordable online fnp programs to become a Family Nurse Practitioner. For those just starting in nursing, cheapest bsn programs online highlight accessible and reputable Bachelor of Science in Nursing options.

If your passion lies in research or teaching future nurses, consider reviewing doctorate in nursing education online programs. With so many online healthcare education choices, you can find a pathway that meets your budget, lifestyle, and career goals.

Best Scientists Citing John G. Gribben

Trending Scientists

Recently Published Articles